In addition, the expression of tight junction proteins (ZO-1, Occludin, Claudin1) was significantly reduced by LY294002 administration, consequently inhibiting the improvement effect of HT, as confirmed by the disappearance of the improvement in Claudin1 immunofluorescence (Fig. 5K-L). The gene discussed is CLDN7; the disease is hematocrit.